Co-Diagnostics Begins Clinical Testing for Respiratory Multiplex PCR Test
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
Read MorePosted by CLP Edit Staff | Nov 21, 2025 | Covid 19, Flu & Respiratory Infections |
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
Read MorePosted by CLP Edit Staff | Nov 12, 2025 | Covid 19, Flu & Respiratory Infections |
The collaboration will provide quality assessment products to support the commercialization of a molecular point-of-care assay for COVID-19 and influenza detection.
Read MorePosted by CLP Edit Staff | Nov 7, 2025 | Lung Cancer |
University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.
Read MorePosted by CLP Edit Staff | Nov 6, 2025 | Cancer |
TAPS+ chemistry preserves DNA integrity in challenging samples including FFPE tissue and circulating tumor DNA.
Read MorePosted by CLP Edit Staff | Nov 3, 2025 | Flu & Respiratory Infections |
Sample-to-answer assay delivers results in approximately 45 minutes from nasopharyngeal and nasal swab specimens.
Read More